Jupiter Neurosciences, Inc. (JUNS)
2.20
+0.07
(+3.29%)
USD |
NASDAQ |
Nov 06, 16:00
2.01
-0.19
(-8.64%)
After-Hours: 20:00
Jupiter Neurosciences Profit Margin (Quarterly) : -9.40K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -9.40K% |
| March 31, 2026 | -11.03K% |
| Date | Value |
|---|---|
| December 31, 2025 | -11.81K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 0.83% |
| ANI Pharmaceuticals, Inc. | 11.25% |
| Corcept Therapeutics, Inc. | 36.56% |
| Veru, Inc. | -- |
| Eli Lilly & Co. | 26.44% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -232.6% |
| Return on Invested Capital | -525.6% |
| Gross Profit Margin (Quarterly) | 87.19% |
| Operating Margin (Quarterly) | -11.33K% |
| Return on Net Operating Assets | -994.4% |